Related Experiment Videos
Therapy of heart failure
T Ecder1, D Korular, A K Gurevich
1Division of Renal Diseases and Hypertension, University of Colorado School of Medicine, Denver 80262, USA. Tevfik.Ecder@UCHSC.edu
Current Opinion in Investigational Drugs (London, England : 2000)
|August 31, 2001
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Respiratory distress with acitretin, reversal by corticosteroid.
Dermatology online journal·2002
The characteristics of infections in crush syndrome.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2002
The Marmara earthquake: epidemiological analysis of the victims with nephrological problems.
Kidney international·2001
Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure.
The Journal of clinical investigation·2001
The outcome of patients presenting with crush syndrome after the Marmara earthquake.
The International journal of artificial organs·2001
Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?
Current opinion in investigational drugs (London, England : 2000)·2011
Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.
Current opinion in investigational drugs (London, England : 2000)·2010
Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.
Current opinion in investigational drugs (London, England : 2000)·2010
Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.
Current opinion in investigational drugs (London, England : 2000)·2010
Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.
Current opinion in investigational drugs (London, England : 2000)·2010
Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.
Current opinion in investigational drugs (London, England : 2000)·2010
BRASH Syndrome Unmasked: Digoxin Toxicity in the Setting of Cardiogenic Shock and Multiorgan Dysfunction.
Case reports in critical care·2026
Impact of reperfusion on thrombectomy outcomes in patients with pre-stroke disability.
Frontiers in neurology·2026